BB Healthcare Trust PLC (BBH) to Issue Dividend of GBX 2.43 on August 30th

Share on StockTwits

BB Healthcare Trust PLC (LON:BBH) announced a dividend on Wednesday, July 17th, Upcoming.Co.Uk reports. Shareholders of record on Thursday, July 25th will be paid a dividend of GBX 2.43 ($0.03) per share on Friday, August 30th. This represents a yield of 1.72%. The ex-dividend date is Thursday, July 25th. This is a boost from BB Healthcare Trust’s previous dividend of $2.00. The official announcement can be seen at this link.

Shares of LON BBH opened at GBX 139.42 ($1.82) on Tuesday. BB Healthcare Trust has a 52-week low of GBX 1.32 ($0.02) and a 52-week high of GBX 150.50 ($1.97). The firm has a 50 day moving average price of GBX 139.78.

In related news, insider Justin Stebbing acquired 4,147 shares of the business’s stock in a transaction dated Friday, June 28th. The shares were acquired at an average price of GBX 140 ($1.83) per share, with a total value of £5,805.80 ($7,586.31).

BB Healthcare Trust Company Profile

BB Healthcare Trust is a closed ended equity mutual fund launched by Bellevue Asset Management AG. The fund is managed by Bellevue Advisors Limited. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies operating across healthcare sector. It seeks to benchmark the performance of its portfolio against the MSCI World Healthcare Index.

Featured Story: Beta

Dividend History for BB Healthcare Trust (LON:BBH)

Receive News & Ratings for BB Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BB Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

JPMorgan Chase & Co. Increases AvalonBay Communities  Price Target to $224.00
JPMorgan Chase & Co. Increases AvalonBay Communities Price Target to $224.00
Brightsphere Investment Group  Lifted to “Hold” at Zacks Investment Research
Brightsphere Investment Group Lifted to “Hold” at Zacks Investment Research
PLDT  Rating Lowered to Hold at Zacks Investment Research
PLDT Rating Lowered to Hold at Zacks Investment Research
AtriCure  Stock Rating Lowered by Northland Securities
AtriCure Stock Rating Lowered by Northland Securities
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Bradesco Corretora Reiterates “Neutral” Rating for Ternium
Meridian Bioscience  Rating Lowered to Sell at ValuEngine
Meridian Bioscience Rating Lowered to Sell at ValuEngine


 
© 2006-2019 Zolmax.